Omega-3 lowers inflammation, blood pressure in obese adults
Cardiovascular disease, or CVD, is a leading cause of death worldwide, and diet strongly influences risk. The American Heart Association recommends reducing saturated fat and increasing polyunsaturated fatty acids, or PUFA, intake, which may cut CVD risk by up to 30%. PUFAs include omega-3 and omega-6, but their direct effects on CVD-related inflammation have not been well compared.

In a recent study, published in the Journal of Lipid Research, Elise Grytten of Haukeland University Hospital and colleagues compared omega-3, or fish oil, and omega-6, or safflower oil, supplements on CVD risk markers. Participants were overweight adults aged 30–70 with abdominal obesity. They received either omega-3 supplements (rich in eicosapentaenoic, or EPA, and docosahexaenoic, or DHA, acids) or omega-6 supplements (rich in linoleic acid) in randomized seven-week sequences. Omega-3 supplements reduced proinflammatory chemokines such as CCL5 and CCL4, suggesting these anti-inflammatory effects could lower CVD risk. Transcriptomic analysis showed overlapping changes in 75 genes across both groups. However, omega-6s’ anti-inflammatory benefits depended on sufficient omega-3 intake. Furthermore, omega-3 lowered blood pressure in participants without hypertension, while omega-6 increased it. Overall, the findings suggest that high-quality omega-3– and omega-6–rich oils may lower the risk of abdominal obesity and cardiometabolic disease. Also, supplementation of omega-6, in contrast to omega-6, appeared to increase adipose inflammation, with unknown clinical relevance.
Despite limitations — including possible carryover effects, unequal supplement doses and small sample size — the authors believe their findings provide new insight into how PUFAs affect adipose inflammation. In the future, they plan to study how omega-6 alters linoleic acid–derived metabolites.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Mapping the placenta’s hormone network
Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.

Spider-like proteins spin defenses to control immunity
Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.